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I spend far too much time flipping through a slim volume
that arrives in my mailbox at the start of every summer.
No, it isn’t a travel brochure for island get-aways. It’s the
Pocket World in Figures, published by The Economist mag-
azine. (I realize I am committing something of a faux pas
by referring to The Economist as a magazine. With a
haughtiness they perhaps have earned, since they’ve been
in business since September 1843, they always refer to
themselves as “this newspaper”. It’s sort of like David
Beckham referring to himself in the third person, I guess.)
I’ve been a subscriber for over 30 years, and along with
the only decent news coverage of the world outside the
United States, one of the other benefits I get is this yearly
little book. 
You can learn all kinds of amazing things just from
opening it at random. For example, the United States has
the second highest divorce rate in the world: 4.8 divorces
per 1,000 population (the UK is 14th, at 3.0; Canada is
29th at 2.3). The country with the highest rate is Aruba
(5.3). Aruba? What on earth is it about Aruba that puts
such a strain on marriages? It can’t be the tourists: no
other Caribbean nation makes the top 40. Certainly can’t
be the weather. Aruba touts itself as a very friendly place;
maybe the people there are too friendly. Anyway, whatever
the reason, there’s something about Aruba that’s appar-
ently incompatible with marital longevity. The country
with the lowest rate is Colombia, with only 0.2 divorces per
1,000 people. The fact that it’s a Catholic country is cer-
tainly part of the reason, but so might be the fact that,
owing to a rather serious crime problem, a large segment of
the population is armed to the teeth. You might think twice
about divorcing your spouse if you know that he - or she -
regularly packs some serious firepower. 
Particularly interesting are the statistics about health and
disease. Swaziland has the highest death rate, 31.2 per 1,000
people. Places 2 through 18 on the list are also held by
African countries where AIDS, malaria and/or tribal wars
are endemic. The lowest death rate, 1.3 per 1,000, is in the
United Arab Emirates. Places 2 through 10 from the lowest
death rate are occupied by other oil-rich, Middle-Eastern
countries, suggesting a correlation between wealth and
health. But it can’t be that: Mexico is 13th and the Philip-
pines is 16th from the top. Neither the US nor the UK even
cracks the top 25. The disease figures are equally fascinating.
The countries with the highest death rates from breast
cancer are all Northern European. The diets and lifestyles
are so different, it makes one wonder if there’s a gene in
there somewhere. Hungary has a lung cancer death rate
almost 20% higher than any other country on earth. And the
US spends more on health care, as a percentage of Gross
Domestic Product, than any other country by a large margin,
yet it is tied with Portugal for 40th on the table of life-
expectancy. Japan, where people live on average 5 years
longer, is not even in the top 30 in health care spending. In
fact, a plot of health care expenditure against either life
expectancy or death rate is a scatter plot, with no apparent
correlation whatsoever. 
We could argue forever about what some of these facts mean,
but I doubt there is a single scientist who wouldn’t find the
data interesting. Most of us become scientists because we are
fascinated by the causes of things, and the causes of death
and disease affect us all. Deducing these causes from a
morass of figures is the work of one of my favorite sciences,
and one that I think should be the closest ally of genomics:
epidemiology. Epidemiology is the study of the factors
involved in the health and illness of individuals and popula-
tions. It’s the cornerstone of both public health and preventa-
tive medicine. Epidemiologists try to establish statistical
relationships between disease agents, both infectious and
non-infectious, and human illness: for example, they were the
first to establish a link between lung cancer and cigarette
smoking. Although human beings have probably speculated
about such connections since the Stone Age, the science of
epidemiology is only about 150 years old. It begins, as so
much of our modern world does, with the Victorians.The summer of 1854 saw the worst cholera epidemic in the
history of London. Over 10,000 people died. It flared up,
seemingly at random, in various spots throughout the
crowded, unsanitary city. As the summer drew to a close,
Soho, which had been spared up to that point, was suddenly
hit hardest of all. The majority of those who died became ill
on the night of 31 August and were dead within days. It is said
that 75% of the population of the city left town that week out
of fear of becoming ill. One who didn’t leave, however, was
London’s most famous physician, Dr John Snow. 
John Snow was born in 1813, the eldest son of a Yorkshire
farmer. Apprenticed to a surgeon at 14, he graduated from
the University of London with his medical doctorate on 20
December, 1844. He had long been fascinated by the mode
of transmission of cholera, and as a young surgeon had actu-
ally written a paper, which was largely ignored, proposing
that contaminated water supply might be the mechanism. In
1846, he became interested in reports from America about
the properties of ether as an anaesthetizing agent. (The
history of anesthesia is one of the most remarkable of all
medical stories, and one that I plan to write about in the
near future.) Experimenting largely on himself, Snow devel-
oped improved methods of administering the drug and
demonstrated its effectiveness in the dental out-patient
clinic at St George’s Hospital. You might think that, as the
man who introduced the use of ether into English surgery,
Snow would have had a vested interest in the continued use
of this drug. But he had a true scientist’s mentality, and
when data began to reach him that chloroform had advan-
tages, he unhesitatingly championed its use. Anesthesia was
scorned for use in child-birth by the (entirely male) medical
establishment of that time, not because of suspicion of its
effectiveness, but because it was thought to be contrary to
the biblical injunction to Eve, “in sorrow thou shalt bring
forth children (Genesis 3:16)”. All that changed, forever, on
the 7 April, 1853, when Snow persuaded Queen Victoria to
use chloroform anesthesia for the birth of Prince Leopold,
her eighth child. This, then, was the doctor who turned his
attention to the cholera epidemic raging through London at
the end of August 1854. 
Medical wisdom at that time held that cholera was spread by
‘miasma in the atmosphere’ (I don’t know quite what that
means, but it sure sounds bad, doesn’t it?). Because of that
belief, nothing was done to contain an epidemic when it
broke out. Snow, however, had already formed the opinion
that contaminated water might be responsible, and the Soho
epidemic gave him his chance. At that time he was living on
Frith Street, right in the heart of the district. He started to
patrol the district. He interviewed the families of victims,
and began to plot on a map of that part of London the deaths
from cholera. He found that nearly all of the deaths had
taken place within a short distance of a water pump on the
corner of Broad and Cambridge Streets. The well was nine
meters deep, but a sewer only seven meters below ground
was just above it. Snow took his findings to the Board of
Guardians of St James’s Parish, where the pump was
located, and persuaded them to remove the pump handle so
no one could obtain water there. The cholera outbreak
stopped almost immediately. 
Although the Victorian medical establishment continued to
express skepticism about Snow’s theory of cholera transmis-
sion, this remarkable demonstration of the power of data
analysis led eventually to improvements in London’s sanita-
tion, including the construction of a proper sewerage system
in the 1880s.  John Snow is widely credited with the inven-
tion of the science of epidemiology. The site of the Broad
Street pump, now the corner of Broadwick and Lexington
Streets in Soho, is the location of a pub, aptly called The John
Snow. A water pump with no handle sits outside. It was
erected there on 28 July, 1992. A picture of the good doctor is
on the pub’s signboard. There’s a room at the back on the
second floor housing an exhibit dedicated to his life and
work; if you ask, you’ll be allowed to go see it. It’s a good pub,
too - a favorite hang-out of mine when I’m in London. You
just might see me there when you visit. Ironically, you would
never see John Snow there: he was a teetotaler. There’s a
society dedicated to promote knowledge of the life of John
Snow and of his works, to encourage communication and col-
laboration between specialists of the many disciplines that
have benefited from Snow’s work, and to ensure that John
Snow’s memory continues to be celebrated in the pub bearing
his name. I’m a member. Since March 2001, the John Snow
Society has been based in the Royal Institute of Public
Health, Portland Place, London. In 2003, John Snow was
voted the greatest doctor of all time in a poll of physicians by
the journal Hospital Doctor. Hippocrates finished second. 
The science of epidemiology that Snow created remains, in
my view, one of the most fascinating, and important, of the
medical sciences. As for why I think it ought to be the closest
allay of genomics, consider the following connections. Both
sciences are data rich. Both depend on finding unexpected
connections within data. Both aim to get at the underlying
causes of things. And where genomics has been sold - I
would claim, oversold for the present - as a key to personal-
ized medicine, epidemiology is where the first glimmerings
that such medicine might even be possible came to light. 
If we could collect and mine enough epidemiological data, it
would tell us where to look for the genes most important to
human health. For example, several human genes that, when
overexpressed, are associated with various cancers have the
property that their deletion or loss of function is associated
with neurodegenerative conditions like Parkinson’s Disease.
(Though surprising, the finding makes sense because cancer
involves cells living that ought to die because of genomic
instability or damage, while neurodegeneration involves the
death of cells that ought to live: they are two sides of what
might be the same coin.) This connection was discovered by
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upregulation of genes in tumors that neurologists had found
using human genetics and the genome sequence to be
mutated in rare, autosomal recessive, familial Parkinson’s
Disease. Yet epidemiologists had already suspected that
there was such a connection, because Parkinson’s patients
tend to have lower than normal incidence of certain cancers.
I think one of the best places to look for new cancer genes is
in the genetic neurologic disorders, and if we want to deter-
mine the pathways to neurodegeneration, we might want to
look closely at genes that are important for tumor survival. 
Similarly, consider the enormous number (hundreds) of
inborn errors of metabolism. Most are recessive, and in
many cases the carriers are asymptomatic. Considering that
many of these conditions have carrier frequencies of 1 in 200
or even greater, the number of carriers in the general popu-
lation is quite high. An obvious question, given the impor-
tance of most of the affected proteins, is whether being a
carrier puts the individual at risk for anything else? Epi-
demiological evidence is mounting that it does. Gaucher
Disease, the most common genetic disorder among Ashke-
nazi Jews, has a carrier frequency in the general population
that is estimated to be as large as 1 in 100. Gaucher carriers
show no symptoms of Gaucher Disease, but epidemiological
data indicate that they may have as much as a 10-fold higher
risk of sporadic, idiopathic Parkinson’s Disease than non-
carriers. I suspect that haploinsufficiency of important meta-
bolic enzymes may underlie many of the ‘sporadic’ diseases.
The right marriage of genomic and epidemiological data
should find these connections, and with them, uncover the
pathways to disease. 
We need to think as broadly as possible about questions like
this. We need the barriers between disciplines to be as low as
possible. We need data from sciences like genomics and epi-
demiology to be freely available in forms that can be under-
stood widely and transferred from one discipline to another
easily. It may be that we need genomics and epidemiology to
become one science. If we had genome sequence information
for whole populations coupled with epidemiologic informa-
tion about health and disease and lifestyle, imagine what a
new generation of John Snows could do with such data. And
imagine what a book of figures that would make!
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